123 related articles for article (PubMed ID: 27356936)
1. "Bridge Proteins" Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics.
Jiang H; Qin G; Zhang X; Che D
Curr Protein Pept Sci; 2017; 18(6):619-629. PubMed ID: 27356936
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
3. Integration of metabolism and inflammation by lipid-activated nuclear receptors.
Bensinger SJ; Tontonoz P
Nature; 2008 Jul; 454(7203):470-7. PubMed ID: 18650918
[TBL] [Abstract][Full Text] [Related]
4. NF-κB, inflammation, and metabolic disease.
Baker RG; Hayden MS; Ghosh S
Cell Metab; 2011 Jan; 13(1):11-22. PubMed ID: 21195345
[TBL] [Abstract][Full Text] [Related]
5. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.
Tornatore L; Thotakura AK; Bennett J; Moretti M; Franzoso G
Trends Cell Biol; 2012 Nov; 22(11):557-66. PubMed ID: 22995730
[TBL] [Abstract][Full Text] [Related]
6. The activation of mTOR is required for monocyte pro-inflammatory response in patients with coronary artery disease.
Gao S; Liu W; Zhuo X; Wang L; Wang G; Sun T; Zhao Z; Liu J; Tian Y; Zhou J; Yuan Z; Wu Y
Clin Sci (Lond); 2015 Apr; 128(8):517-26. PubMed ID: 25428582
[TBL] [Abstract][Full Text] [Related]
7. NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment.
Dáňová K; Klapetková A; Kayserová J; Šedivá A; Špíšek R; Jelínková LP
Oncotarget; 2015 Jun; 6(16):14123-38. PubMed ID: 26053099
[TBL] [Abstract][Full Text] [Related]
8. Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2016.
Rosa Neto JC; Lira FS; Roy S; Festuccia W
Mediators Inflamm; 2017; 2017():8230298. PubMed ID: 28757685
[No Abstract] [Full Text] [Related]
9. Apocynin inhibits Toll-like receptor-4-mediated activation of NF-κB by suppressing the Akt and mTOR pathways.
Nam YJ; Kim A; Sohn DS; Lee CS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1267-1277. PubMed ID: 27590200
[TBL] [Abstract][Full Text] [Related]
10. Oxysterols in Metabolic Syndrome: From Bystander Molecules to Bioactive Lipids.
Guillemot-Legris O; Mutemberezi V; Muccioli GG
Trends Mol Med; 2016 Jul; 22(7):594-614. PubMed ID: 27286741
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
Sarkar FH; Li Y; Wang Z; Kong D
Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
[TBL] [Abstract][Full Text] [Related]
12. PPARs at the crossroads of lipid signaling and inflammation.
Wahli W; Michalik L
Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB regulation in the immune system.
Li Q; Verma IM
Nat Rev Immunol; 2002 Oct; 2(10):725-34. PubMed ID: 12360211
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 Regulates Flagellin-Induced Inflammatory Response in Macrophages.
Bao W; Wang Y; Fu Y; Jia X; Li J; Vangan N; Bao L; Hao H; Wang Z
PLoS One; 2015; 10(5):e0125910. PubMed ID: 25942007
[TBL] [Abstract][Full Text] [Related]
16. Brefeldin A reduces tumor necrosis factor-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR, and NF-κB pathways in human keratinocytes.
Nam YJ; Lee CS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):951-60. PubMed ID: 27198515
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and gastrointestinal cancer: an overview.
Marusawa H; Jenkins BJ
Cancer Lett; 2014 Apr; 345(2):153-6. PubMed ID: 23981579
[TBL] [Abstract][Full Text] [Related]
18. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress in Metabolic Disorders and Drug-Induced Injury: The Potential Role of Nrf2 and PPARs Activators.
Mahmoud AM; Alexander MY; Tutar Y; Wilkinson FL; Venditti A
Oxid Med Cell Longev; 2017; 2017():2508909. PubMed ID: 29348787
[No Abstract] [Full Text] [Related]
20. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway.
Lee KC; Chang HH; Chung YH; Lee TY
J Ethnopharmacol; 2011 Jun; 135(3):678-84. PubMed ID: 21497192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
